In silico analysis of selected components of grapefruit seed extract against SARS-CoV-2 main protease

1WHO Coronavirus Disease (COVID-19) Dashboard. [Cited 2021 May 09]. Available from: https://covid19.who.int/ WHO Coronavirus Disease (COVID-19) Dashboard [Cited 2021 May 09]. Available from https://covid19.who.int/Search in Google Scholar

2Ouassou H, Kharchoufa L, Bouhrim M, Daoudi NE, Imtara H, Bencheikh N, et al. The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention. J Immunol Res. 2020;2020:7. Ouassou H Kharchoufa L Bouhrim M Daoudi NE Imtara H Bencheikh N et al The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention J Immunol Res 20202020710.1155/2020/1357983735212732671115Search in Google Scholar

3The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)-China. China CDC Weekly. 2020;2:113–122. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)-China China CDC Weekly 2020211312210.46234/ccdcw2020.032Search in Google Scholar

4Woo PCY, Huang Y, Lau SKP, Yuen K-Y. Coronavirus Genomics and Bioinformatics Analysis. Viruses. 2010;2(8):1804–1820. Woo PCY Huang Y Lau SKP Yuen K-Y. Coronavirus Genomics and Bioinformatics Analysis Viruses 2010281804182010.3390/v2081803318573821994708Search in Google Scholar

5Xue X, Yu H, Yang H, Xue F, Wu Z, Shen W, et al. Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design. J Virol. 2007;82(5), 2515–2527. Xue X Yu H Yang H Xue F Wu Z Shen W et al Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design J Virol 2007825 2515252710.1128/JVI.02114-07225891218094151Search in Google Scholar

6Motiwale M, Yadav NS, Kumar S, Kushwaha T, Choudhir G, Sharma S, et al. Finding potent inhibitors for COVID-19 main protease (Mpro): an in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA. J Biomol Struct Dyn. 2020;1-12. Motiwale M Yadav NS Kumar S Kushwaha T Choudhir G Sharma S et al Finding potent inhibitors for COVID-19 main protease (Mpro): an in silico approach using SARS-CoV-3CL protease inhibitors for combating CORONA J Biomol Struct Dyn 202011210.1080/07391102.2020.182950133030102Search in Google Scholar

7Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 2020; 368(6489):409-412. Zhang L Lin D Sun X Curth U Drosten C Sauerhering L et al Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors Science 2020 368648940941210.1126/science.abb3405716451832198291Search in Google Scholar

8Yang H, Xie W, Xue X, Yang K, Ma J, Liang W, et al. Correction: Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases. PLoS Biol. 2005;3(11):e428. Yang H Xie W Xue X Yang K Ma J Liang W et al Correction: Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases PLoS Biol 2005311e42810.1371/journal.pbio.0030428Search in Google Scholar

9Sacco MD, Ma C, Lagarias P, Gao A, Townsend JA, Meng X, et al. Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L. Sci Adv. 2020;6(50):eabe0751. Sacco MD Ma C Lagarias P Gao A Townsend JA Meng X et al Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L Sci Adv 2020650eabe075110.1101/2020.07.27.223727740205932766590Search in Google Scholar

10Ul Qamar M, Alqahtani S, Alamri MA, Chen L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10(4):313-319. Ul Qamar M Alqahtani S Alamri MA Chen L Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants J Pharm Anal 202010431331910.1016/j.jpha.2020.03.009715622732296570Search in Google Scholar

11Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs. Science. 2003;300(5626):1763–1767. Anand K Ziebuhr J Wadhwani P Mesters JR Hilgenfeld R Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs Science 200330056261763176710.1126/science.108565812746549Search in Google Scholar

12Kumar Y, Singh H, Patel CN. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. J Infect Public Health. 2020;13(9):1210-1223. Kumar Y Singh H Patel CN In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing J Infect Public Health 20201391210122310.1016/j.jiph.2020.06.016729771832561274Search in Google Scholar

13Cvetnic Z, Vladimir-Knezevic S. Antimicrobial activity of grapefruit seed and pulp ethanolic extract. Acta Pharm. 2004;54:243–250. Cvetnic Z Vladimir-Knezevic S Antimicrobial activity of grapefruit seed and pulp ethanolic extract Acta Pharm 200454243250Search in Google Scholar

14Shahnawaz A, Rattanpal HS, Singh G. Diversity assessment of grapefruit (citrus × paradisi) and tangelo (citrus × tangelo) under indian conditions using physico-chemical parameters and ssr markers. App Ecol Environ Res. 2018;16(5):5343-5358. Shahnawaz A Rattanpal HS Singh G Diversity assessment of grapefruit (citrus × paradisi) and tangelo (citrus × tangelo) under indian conditions using physico-chemical parameters and ssr markers App Ecol Environ Res 20181655343535810.15666/aeer/1605_53435358Search in Google Scholar

15Notice to the US Food and Drug Administration that the use of Vancitrix™, a glycerin Citrus Extract, is Generally Recognized as Safe. [Cited 2021 Feb 27]. Available from: https://www.fda.gov/media/99981/download Notice to the US Food and Drug Administration that the use of Vancitrix™, a glycerin Citrus Extract, is Generally Recognized as Safe [Cited 2021 Feb 27]. Available from https://www.fda.gov/media/99981/downloadSearch in Google Scholar

16Cardellina JH. Grapefruit Seed Extract Laboratory Guidance Document. American Botanical Council. 2017. [Cited 2021 Feb 27]. Available from: http://cms.herbalgram.org/BAP/LGD/ABC-LGDs-GFSE-CC-05092017-v5.pdf Cardellina JH Grapefruit Seed Extract Laboratory Guidance Document. American Botanical Council 2017 [Cited 2021 Feb 27]. Available from http://cms.herbalgram.org/BAP/LGD/ABC-LGDs-GFSE-CC-05092017-v5.pdfSearch in Google Scholar

17Komura M, Suzuki M, Sangsriratanakul N, Ito M, Takahashi S, Alam MS, et al. Inhibitory effect of grapefruit seed extract (GSE) on avian pathogens. J Vet Med Sci. 2019;81(3):466-472. Komura M Suzuki M Sangsriratanakul N Ito M Takahashi S Alam MS et al Inhibitory effect of grapefruit seed extract (GSE) on avian pathogens J Vet Med Sci 201981346647210.1292/jvms.18-0754645189630713281Search in Google Scholar

18Go CC, Pandav K, Sanchez-Gonzalez MA, Ferrer G. Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series. Cureus. 2020;12(11):e11315. Go CC Pandav K Sanchez-Gonzalez MA Ferrer G Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series Cureus 20201211e1131510.7759/cureus.11315764529733173650Search in Google Scholar

19Shalayel M, Al-Mazaideh G, Aladaileh SH, Al-Swailmi F, Al-Thiabat M. Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15. Pak J Pharm Sci. 2020;33(5):2179-2186. Shalayel M Al-Mazaideh G Aladaileh SH Al-Swailmi F Al-Thiabat M Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15 Pak J Pharm Sci 202033521792186Search in Google Scholar

20Teli DM, Shah MB, Chhabria MT. In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19. Front Mol Biosci. 2021;7:429. Teli DM Shah MB Chhabria MT In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19 Front Mol Biosci 2021742910.3389/fmolb.2020.599079785245633542917Search in Google Scholar

21Sharma S, Deep S. In-Silico Drug Repurposing for Targeting SARS-CoV-2 Mpro. ChemRxiv. 2020; Preprint. Available from: https://doi.org/10.26434/chemrxiv.12210845.v1 Sharma S Deep S In-Silico Drug Repurposing for Targeting SARS-CoV-2 Mpro ChemRxiv 2020 Preprint. Available from https://doi.org/10.26434/chemrxiv.12210845.v110.26434/chemrxiv.12210845.v1Search in Google Scholar

22Alrasheid AA, Babiker MY, Awad TA. Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis. In Silico Pharmacol. 2021; 9(1):10. Alrasheid AA Babiker MY Awad TA Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis In Silico Pharmacol 2021 911010.1007/s40203-020-00073-8778765233432283Search in Google Scholar

23Ibrahim MAA, Abdelrahman AHM, Allemailem KS, Almatroudi A, Moustafa MF, Hegazy MEF. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors. Protein J. 2021. Ibrahim MAA Abdelrahman AHM Allemailem KS Almatroudi A Moustafa MF Hegazy MEF In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors Protein J 202110.1007/s10930-020-09945-6777632233387249Search in Google Scholar

24Kumar Y, Singh H, Patel CN. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. J Infect Public Health. 2020;13(9). Kumar Y Singh H Patel CN In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing J Infect Public Health 202013910.1016/j.jiph.2020.06.016Search in Google Scholar

25Garibaldi BT, Wang K, Robinson ML, et al. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19. JAMA Netw Open. 2021;4(3):e213071. Garibaldi BT Wang K Robinson ML et al Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19 JAMA Netw Open 202143e21307110.1001/jamanetworkopen.2021.3071799197533760094Search in Google Scholar

26Lai C-C, Chen C-H, Wang C-Y, Chen, Ya-Hui Wang K-H, Hsueh P-R. Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials. J Antimi-crob Chemother. 2021;dkab093. Lai C-C Chen C-H Wang C-Y Chen Ya-Hui Wang K-H Hsueh P-R Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials J Antimi-crob Chemother 2021dkab09310.1093/jac/dkab093808372833758946Search in Google Scholar

27RCSB Protein Data Bank. [Cited 2021 Feb 27]. Available from: https://www.rcsb.org/ RCSB Protein Data Bank [Cited 2021 Feb 27]. Available from https://www.rcsb.org/Search in Google Scholar

28PubChem. [Cited 2021 Feb 27]. Available from https://pubchem.ncbi.nlm.nih.gov/ PubChem [Cited 2021 Feb 27]. Available from https://pubchem.ncbi.nlm.nih.gov/Search in Google Scholar

29Online SMILES Translator and Structure File Generator. [Cited 2021 Feb 27]. Available from: https://cactus.nci.nih.gov/translate/ Online SMILES Translator and Structure File Generator [Cited 2021 Feb 27]. Available from https://cactus.nci.nih.gov/translate/Search in Google Scholar

30MGLTools. [Cited 2021 Feb 27]. Available from http://mgltools.scripps.edu/downloads MGLTools [Cited 2021 Feb 27]. Available from http://mgltools.scripps.edu/downloadsSearch in Google Scholar

31Trott O, Olson, A. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem. 2010;31(2):455-461. Trott O Olson A. AutoDock Vina improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading J Comput Chem 201031245546110.1002/jcc.21334304164119499576Search in Google Scholar

32Narkhede RR, Pise AV, Cheke RS, Shinde SD. Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences. Nat Prod Bio-prospect. 2020a;10:297–306. Narkhede RR Pise AV Cheke RS Shinde SD Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences Nat Prod Bio-prospect 2020a1029730610.1007/s13659-020-00253-1729945932557405Search in Google Scholar

33The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC. [Cited 2021 Feb 27]. Available from https://pymol.org/2/ The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC [Cited 2021 Feb 27]. Available from https://pymol.org/2/Search in Google Scholar

34Narkhede RR, Cheke RS, Ambhore JP, Shinde SD. The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2. EJMO. 2020b;4(3):185–195. Narkhede RR Cheke RS Ambhore JP Shinde SD The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2 EJMO 2020b43185195Search in Google Scholar

35Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Targeted Ther. 2020;5:237. Dong Y Dai T Wei Y Zhang L Zheng M Zhou F A systematic review of SARS-CoV-2 vaccine candidates Signal Transduct Targeted Ther 2020523710.1038/s41392-020-00352-y755152133051445Search in Google Scholar

36Iacob S, Iacob DG. SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus. Front Pharmacol. 2020;11:1224. Iacob S Iacob DG SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus Front Pharmacol 202011122410.3389/fphar.2020.01224747923232982720Search in Google Scholar

37Afriza D, Suriyah WH, Ichwan SJA. In silico analysis of molecular interactions between the antiapoptotic protein survivin and dentatin, nordentatin, andquercetin. J Phys Conf Ser. 2018;1073(3):032001. Afriza D Suriyah WH Ichwan SJA In silico analysis of molecular interactions between the antiapoptotic protein survivin and dentatin, nordentatin, andquercetin J Phys Conf Ser 20181073303200110.1088/1742-6596/1073/3/032001Search in Google Scholar

38Saxena A. Drug targets for COVID-19 therapeutics: Ongoing global efforts. J Biosci. 2020;45(1):87. Saxena A Drug targets for COVID-19 therapeutics: Ongoing global efforts J Biosci 20204518710.1007/s12038-020-00067-wSearch in Google Scholar

39Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo MA, et al. COVID-19: Drug Targets and Potential Treatments. J Med Chem. 2020;63(21):12359–12386. Gil C Ginex T Maestro I Nozal V Barrado-Gil L Cuesta-Geijo MA et al COVID-19: Drug Targets and Potential Treatments J Med Chem 20206321123591238610.1021/acs.jmedchem.0c00606732306032511912Search in Google Scholar

40Vijayakumar BG, Ramesh D, Joji A, Prakasan JJ, Kannan T. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. Eur J Pharmacol. 2020;886:173448. Vijayakumar BG Ramesh D Joji A Prakasan JJ Kannan T In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2 Eur J Pharmacol 202088617344810.1016/j.ejphar.2020.173448740643232768503Search in Google Scholar

41Cherrak SA, Merzouk H, Mokhtari-Soulimane N. Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies. PLOS ONE. 2020;15(10):e0240653. Cherrak SA Merzouk H Mokhtari-Soulimane N Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies PLOS ONE 20201510e024065310.1371/journal.pone.0240653756114733057452Search in Google Scholar

42Vardhan S, Sahoo SK. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Comput Biol Med. 2020;124:103936. Vardhan S Sahoo SK In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19 Comput Biol Med 202012410393610.1016/j.compbiomed.2020.103936738649632738628Search in Google Scholar

43Gualdani R, Cavalluzzi MM, Lentini G, Habtemariam S. The Chemistry and Pharmacology of Citrus Limonoids. Molecules. 2016;21(11):1530. Gualdani R Cavalluzzi MM Lentini G Habtemariam S The Chemistry and Pharmacology of Citrus Limonoids Molecules 20162111153010.3390/molecules21111530627327427845763Search in Google Scholar